Compare WTFC & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WTFC | TWST |
|---|---|---|
| Founded | 1991 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 9.2B |
| IPO Year | 1996 | 2018 |
| Metric | WTFC | TWST |
|---|---|---|
| Price | $144.87 | $149.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 13 |
| Target Price | ★ $176.20 | $150.33 |
| AVG Volume (30 Days) | 482.7K | ★ 2.7M |
| Earning Date | 10-19-2026 | 11-13-2026 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | 10.57 | ★ 63.89 |
| EPS | ★ 6.52 | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | $9.10 | $21.18 |
| Revenue Next Year | $6.63 | $20.16 |
| P/E Ratio | $21.97 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $119.67 | $23.30 |
| 52 Week High | $167.22 | $219.71 |
| Indicator | WTFC | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 43.96 | 45.65 |
| Support Level | $143.58 | $117.74 |
| Resistance Level | $148.30 | $155.44 |
| Average True Range (ATR) | 2.68 | 16.17 |
| MACD | 0.34 | -5.11 |
| Stochastic Oscillator | 72.34 | 7.36 |
Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. Its operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.